Hong SJ - Search Results

1

The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.

Lee SH, Kim DK, Kim JC, Lee KS, Lee JG, Park CH, Hong SJ, Kim CS, Park JK, Chung BH. Lee SH, et al. Among authors: hong sj. Yonsei Med J. 2010 May;51(3):432-7. doi: 10.3349/ymj.2010.51.3.432. Yonsei Med J. 2010. PMID: 20376898 Free PMC article.

2

Proper cut-off value of free to total PSA ratio for detection of prostate cancer in Korean men.

Im YJ, Kim JW, Hong SJ, Chung BH. Im YJ, et al. Among authors: hong sj. Yonsei Med J. 2004 Oct 31;45(5):873-8. doi: 10.3349/ymj.2004.45.5.873. Yonsei Med J. 2004. PMID: 15515198 Free article.

3

A prospective, multicenter, open-label trial of zoledronic acid in patients with hormone refractory prostate cancer.

Hong SJ, Cho KS, Cho HY, Ahn H, Kim CS, Chung BH. Hong SJ, et al. Yonsei Med J. 2007 Dec 31;48(6):1001-8. doi: 10.3349/ymj.2007.48.6.1001. Yonsei Med J. 2007. PMID: 18159593 Free PMC article. Clinical Trial.

4

Unrecognized kinetics of serum testosterone: impact on short-term androgen deprivation therapy for prostate cancer.

Koo KC, Lee DH, Kim KH, Lee SH, Hong CH, Hong SJ, Chung BH. Koo KC, et al. Among authors: hong sj, hong ch. Yonsei Med J. 2014 May;55(3):570-5. doi: 10.3349/ymj.2014.55.3.570. Epub 2014 Apr 1. Yonsei Med J. 2014. PMID: 24719121 Free PMC article. Clinical Trial.

5

Is high-dose leuprorelin acetate effective and safe in asian men with prostate cancer? An open-label, non-comparative, multi-center clinical trial.

Lee SH, Lee HM, Kim SW, Lee ES, Hong SJ, Kim CS, Kang TW, Chung BH. Lee SH, et al. Among authors: hong sj. Yonsei Med J. 2014 Mar;55(2):310-5. doi: 10.3349/ymj.2014.55.2.310. Yonsei Med J. 2014. PMID: 24532497 Free PMC article. Clinical Trial.

6

Identification of baseline clinical factors which predict medical treatment failure of benign prostatic hyperplasia: an observational cohort study.

Hong SJ, Ko WJ, Kim SI, Chung BH. Hong SJ, et al. Eur Urol. 2003 Jul;44(1):94-9; discussion 99-100. doi: 10.1016/s0302-2838(03)00199-4. Eur Urol. 2003. PMID: 12814681

7

Can a 12 core prostate biopsy increase the detection rate of prostate cancer versus 6 core?: a prospective randomized study in Korea.

Kim JW, Lee HY, Hong SJ, Chung BH. Kim JW, et al. Among authors: hong sj. Yonsei Med J. 2004 Aug 31;45(4):671-5. doi: 10.3349/ymj.2004.45.4.671. Yonsei Med J. 2004. PMID: 15344209 Free article. Clinical Trial.

8

Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.

Chung BH, Hong SJ, Lee MS. Chung BH, et al. Among authors: hong sj. Int J Urol. 2005 Feb;12(2):159-65. doi: 10.1111/j.1442-2042.2005.00998.x. Int J Urol. 2005. PMID: 15733110 Clinical Trial.

9

Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.

Chung BH, Hong SJ. Chung BH, et al. Among authors: hong sj. BJU Int. 2006 Jan;97(1):90-5. doi: 10.1111/j.1464-410X.2006.05858.x. BJU Int. 2006. PMID: 16336335

10

Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.

Chung BH, Hong SJ, Cho JS, Seong DH. Chung BH, et al. Among authors: hong sj. BJU Int. 2006 Apr;97(4):742-6. doi: 10.1111/j.1464-410X.2006.06016.x. BJU Int. 2006. PMID: 16536765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,792 results

Search Page

Filters